Zhengxin Group Donates 1.5 Mil Boxes of Masks to Cities in China

On December 10, 2022, Zhengxin Group, a leading personal protective equipment (PPE) manufacturer headquartered in mainland China, announced that they have donated over 1.5 million boxes of masks to various cities within China. The donation aims to help ease the effects of the COVID-19 pandemic following the lifting of lockdowns by the Chinese government in early December.

The new policy in China allows citizens across China to move freely for the first time since the pandemic started in early 2020. However, within the first days of the new policy, new cases surged to over 50,000 per day, causing a massive rise in the demand for face masks.

Zhengxin Group is preparing to donate a warehouse of 1.5 million boxes of masks

“For more than 10 years, Zhengxin has been one of the cooperative suppliers of the Chinese government’s national strategic material reserve, and we are honored to have the opportunity to contribute to the fight against COVID-19, which is our corporate social responsibility,” CEO of Zhengxin Group Danny Peng said. “We have been committed to providing reliable security protection for medical workers around the world, and creating value for our suppliers and employees.”

The mask donation is a manifestation of the performance of Zhengxin Group’s high-efficiency production model through the introduction of fully automated mask production machines in November. Zhengxin will continue to invest in research and development technology to develop high-capacity production equipment to prepare for the next possible virus.

The hightened demand for coverings emptied face masks from pharmacies across the county. In response, Zhengxin Group announced that it will donate 1.5 million boxes of masks from its existing safety stock to various places in China with Beijing, Shanghai and Shenzhen accounting for 45% of the total donations.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.